Bim is elevated in Alzheimer's disease neurons and is required for β-amyloid-induced neuronal apoptosis

被引:90
作者
Biswas, Subhas C.
Shi, Yijie
Vonsattel, Jean-Paul G.
Leung, Conrad L.
Troy, Carol M.
Greene, Lloyd A.
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Pathol, Ctr Neurobiol & Behav, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
关键词
neuronal apoptosis; BH3; only; cell cycle; Alzheimer's disease; Bim; A beta peptide;
D O I
10.1523/JNEUROSCI.3524-06.2007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The molecules that mediate neuron death in Alzheimer's disease (AD) are largely unknown. We report that beta-amyloid (A beta), a death-promoting peptide implicated in the pathophysiology of AD, induces the proapoptotic protein Bcl-2 interacting mediator of cell death (Bim) in cultured hippocampal and cortical neurons. We further find that Bim is an essential mediator of A beta-induced neurotoxicity. Our examination of postmortem AD human brains additionally reveals upregulation of Bim in vulnerable entorhinal cortical neurons, but not in cerebellum, a region usually unaffected by AD. Accumulating evidence links inappropriate induction/activation of cell cycle-related proteins to AD, but their roles in the disease have been unclear. We find that the cell cycle molecule cyclin-dependent kinase 4 (cdk4) and its downstream effector B-myb, are required for A beta-dependent Bim induction and death in cultured neurons. Moreover, neurons that overexpress Bim in AD brains also show elevated levels of the cell cycle-related proteins cdk4 and phospho-Rb. Our observations indicate that Bim is a proapoptotic effector of A beta and of dysregulated cell cycle proteins in AD and identify both Bim and cell cycle elements as potential therapeutic targets.
引用
收藏
页码:893 / 900
页数:8
相关论文
共 44 条
[1]  
Angelastro JM, 2003, J NEUROSCI, V23, P4590
[2]   Globular amyloid β-peptide1-42 oligomer -: a homogenous and stable neuropathological protein in Alzheimer's disease [J].
Barghorn, S ;
Nimmrich, V ;
Striebinger, A ;
Krantz, C ;
Keller, P ;
Janson, B ;
Bahr, M ;
Schmidt, M ;
Bitner, RS ;
Harlan, J ;
Barlow, E ;
Ebert, U ;
Hillen, H .
JOURNAL OF NEUROCHEMISTRY, 2005, 95 (03) :834-847
[3]   Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis [J].
Becker, EBE ;
Howell, J ;
Kodama, Y ;
Barker, PA ;
Bonni, A .
JOURNAL OF NEUROSCIENCE, 2004, 24 (40) :8762-8770
[4]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[5]   Bim is a direct target of a neuronal E2F-dependent apoptotic pathway [J].
Biswas, SC ;
Liu, DX ;
Greene, LA .
JOURNAL OF NEUROSCIENCE, 2005, 25 (37) :8349-8358
[6]   Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation [J].
Biswas, SC ;
Greene, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) :49511-49516
[7]  
Busser J, 1998, J NEUROSCI, V18, P2801
[8]   Mechanisms of neuronal death in Alzheimer's disease [J].
Cotman, CW ;
Su, JH .
BRAIN PATHOLOGY, 1996, 6 (04) :493-506
[9]  
COTMAN CW, 1994, ANN NY ACAD SCI, V747, P36
[10]   Expression of apoptosis related proteins in brains of patients with Alzheimer's disease [J].
Engidawork, E ;
Gulesserian, T ;
Seidl, R ;
Cairns, N ;
Lubec, G .
NEUROSCIENCE LETTERS, 2001, 303 (02) :79-82